622. Lymphomas: Translational Non-Genetic: Poster I

Immune cell dynamics following rituximab and epcoritamab as first-line therapy for patients with high-tumor burden follicular lymphoma

Non-invasive Mantle Cell Lymphoma risk stratification by inference of tumor proliferation from cfDNA

Longitudinal single-cell profiling in canine DLBCL reveals regulatory networks driving chemotherapy resistance.

The effects of bruton tyrosine kinase inhibitors on the waldenstrom macroglobulinemia microenvironment

Enhancing the expansion of Naive, potent T-cells via BTK inhibition reinvigorates CD19-CAR T-cell immunity and boosts antitumor efficacy in relapsed Mantle Cell Lymphoma

Deep learning-based histopathological subtyping of peripheral T-cell lymphoma (PTCL) on H&E-stained whole slide images

Multimodal discovery of distinct tumor ecosystems for classic Hodgkin lymphoma

Multi-omic spatial profiling of EBV+ hodgkinoid lymphoproliferation reveals divergent biological features and novel diagnostic biomarkers.

Idiotype mRNA therapeutic vaccination in a mouse model of B cell lymphoma

Higher helios treg levels pre- and post-CAR T infusion are associated with inferior outcomes in patients with LBCL

Combination of golidocitinib with chidamide for peripheral T-cell lymphoma: Possible mechanisms and therapeutic potential in inhibiting tumor proliferation and modulating the immune microenvironment

A genetic comparison of epstein-barr virus-associated polymorphic lymphoproliferative disorder and diffuse large B cell lymphoma

INSIGHT: A baseline laboratory profile independently predicts outcomes and demonstrates superiority of lisocabtagene maraleucel (liso-cel) over standard of care (SOC) in second-line (2L) large B-cell lymphoma (LBCL) regardless of baseline profile

Cell differentiation stage drives mechanisms of apoptosis evasion in Waldenstroem macroglobulinemia

Dual HDAC and EZH2 inhibition modulates RFX5 activity to increase the immunogenicity of germinal center-derived B-cell lymphoma